The paper's citation list
No. | The paper's citation list |
|---|
1 | Current status and prospects for pancreatic cancer diagnosis by exosome-based liquid biopsy. 2023;38:19 doi: 10.2958/suizo.38.19 |
2 | Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer. 2023;102 doi: 10.37349/etat.2023.00125 |
3 | Multiplexed Profiling of Extracellular Vesicles for Biomarker Development. 2022;14: doi: 10.1007/s40820-021-00753-w |
4 | Toward the definition of common strategies for improving reproducibility, standardization, management, and overall impact of academic research. 2022;35:1 doi: 10.1016/bs.abl.2022.05.001 |
5 | In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum. 2024;23:386 doi: 10.1021/acs.jproteome.3c00614 |
6 | Extracellular vesicle‐bound DNA in urine is indicative of kidney allograft injury. 2022;11: doi: 10.1002/jev2.12268 |
7 | The times they are AI-changing: AI-powered advances in the application of extracellular vesicles to liquid biopsy in breast cancer. 2025;6:128 doi: 10.20517/evcna.2024.51 |
8 | Screening and Risk Reduction Strategies for Breast Cancer. 2023;127 doi: 10.1007/978-981-19-7630-8_9 |
9 | EV‐ADD, a database for EV‐associated DNA in human liquid biopsy samples. 2022;11: doi: 10.1002/jev2.12270 |
10 | Quality Management Tools on the Stage: Old but New Allies for Rigor and Standardization of Extracellular Vesicle Studies. 2022;10: doi: 10.3389/fbioe.2022.826252 |
